424B5IMMXCIK 0001873835

Immix Biopharma, Inc.

Name: SEC EDGAR filing 0001493152-26-044771
Creator: Immix Biopharma, Inc.
License: https://www.usa.gov/government-works

Prospectus supplement (424B5) filed September 29, 2026.

Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.

Open the filing on SEC.gov

Filing facts

Accession number: 0001493152-26-044771
Filer: Immix Biopharma, Inc.
Ticker: IMMX
CIK: 0001873835
Form type: 424B5
Form description: Prospectus supplement
Filed at: September 29, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 29, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1873835/000149315226044771/0001493152-26-044771-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Immix Biopharma, Inc. (0001873835) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001493152-26-044771.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.